单期双能CT在门静脉期鉴别血管性与非血管性肾脏偶发病变的诊断效能:与CT比较
回顾性纳入250例患者266个肾脏病变,评估单期门静脉期双能CT鉴别血管性与非血管性肾脏病变的诊断效能,并确定最佳碘阈值与HU测量比较。归一化碘浓度阈值0.25 mg/mL鉴别血管性与非血管性病变AUC 0.93,与HU测量(AUC 0.93)相当;两者联合AUC 0.96;鉴别血管性病变与出血/蛋白性囊肿时碘浓度优于HU(AUC 0.92 vs 0.87)。
要点
- 门静脉期单期双能CT鉴别肾脏血管性与非血管性病变准确性高(AUC 0.93)。
- 归一化碘浓度阈值0.25 mg/mL用于鉴别,与HU测量效能相当(AUC 0.93 vs 0.93)。
- 碘浓度与HU联合诊断效能最高(AUC 0.96)。
核心结论
- 门静脉期单期双能CT能高准确度鉴别血管性与非血管性肾脏病变;碘浓度在鉴别血管性病变与出血/蛋白性囊肿时略优于HU测量。
研究设计与样本
- 回顾性纳入250例患者(266个肾脏病变),行临床指征的门静脉期腹盆腔CT,使用快速管电压切换单源双能CT(rsDECT)或双源双能CT(dsDECT)扫描仪;由4名经验丰富的阅片者测量碘浓度和HU;以活检结果和随访影像为参考标准。
关键影像表现/征象
- 肾脏病变在门静脉期双能CT上通过碘浓度和HU测量区分血管性与非血管性。
- 归一化碘浓度阈值0.25 mg/mL鉴别血管性与非血管性病变AUC 0.93(p < 0.001)。
- HU测量鉴别血管性与非血管性病变AUC 0.93。
- 碘浓度与HU联合鉴别血管性与非血管性病变AUC 0.96。
- 鉴别血管性病变与出血/蛋白性囊肿:碘浓度AUC 0.92 vs HU测量AUC 0.87。
诊断标准与关键数值
- 归一化碘浓度阈值0.25 mg/mL鉴别血管性与非血管性肾脏病变,AUC 0.93(p < 0.001)。
- HU测量鉴别血管性与非血管性肾脏病变AUC 0.93。
- 调整年龄、性别、体重指数和病变大小后,碘浓度和HU测量均独立与血管性病变相关(AUC分别为0.95和0.95)。
- 碘浓度与HU联合鉴别血管性与非血管性病变AUC 0.96。
- 鉴别血管性病变与出血/蛋白性囊肿:绝对和归一化碘浓度AUC 0.92 vs HU测量AUC 0.87。
临床应用与阅片要点
- 门静脉期单期双能CT可用于鉴别肾脏偶发病变的血管性与非血管性。
- 归一化碘浓度0.25 mg/mL可作为鉴别血管性与非血管性肾脏病变的阈值。
- 碘浓度与HU测量联合可提高鉴别血管性与非血管性肾脏病变的效能(AUC 0.96)。
- 鉴别血管性病变与出血/蛋白性囊肿时,碘浓度测量略优于HU测量(AUC 0.92 vs 0.87)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether single-phase dual-energy CT (DECT) differentiates vascular and nonvascular renal lesions in the portal venous phase (PVP). Optimal iodine threshold was determined and compared to Hounsfield unit (HU) measurements.
METHODS: We retrospectively included 250 patients (266 renal lesions) who underwent a clinically indicated PVP abdominopelvic CT on a rapid-kilovoltage-switching single-source DECT (rsDECT) or a dual-source DECT (dsDECT) scanner. Iodine concentration and HU measurements were calculated by four experienced readers. Diagnostic accuracy was determined using biopsy results and follow-up imaging as reference standard. Area under the curve (AUC) was calculated for each DECT scanner to differentiate vascular from nonvascular lesions and vascular lesions from hemorrhagic/proteinaceous cysts. Univariable and multivariable logistic regression analyses evaluated the association between variables and the presence of vascular lesions.
RESULTS: A normalized iodine concentration threshold of 0.25 mg/mL yielded high accuracy in differentiating vascular and nonvascular lesions (AUC 0.93, p < 0.001), with comparable performance to HU measurements (AUC 0.93). Both iodine concentration and HU measurements were independently associated with vascular lesions when adjusted for age, gender, body mass index, and lesion size (AUC 0.95 and 0.95, respectively). When combined, diagnostic performance was higher (AUC 0.96). Both absolute and normalized iodine concentrations performed better than HU measurements (AUC 0.92 vs. AUC 0.87) in differentiating vascular lesions from hemorrhagic/proteinaceous cysts.
CONCLUSION: A single-phase (PVP) DECT scan yields high accuracy to differentiate vascular from nonvascular renal lesions. Iodine concentration showed a slightly higher performance than HU measurements in differentiating vascular lesions from hemorrhagic/proteinaceous cysts.
KEY POINTS: • A single-phase dual-energy CT scan in the portal venous phase differentiates vascular from nonvascular renal lesions with high accuracy (AUC 0.93). • When combined, iodine concentration and HU measurements showed the highest diagnostic performance (AUC 0.96) to differentiate vascular from nonvascular renal lesions. • Compared to HU measurements, iodine concentration showed a slightly higher performance in differentiating vascular lesions from hemorrhagic/proteinaceous cysts.
引用
- Mastrodicasa D, Willemink MJ, Madhuripan N, et al. Diagnostic performance of single-phase dual-energy CT to differentiate vascular and nonvascular incidental renal lesions on portal venous phase: comparison with CT. Eur Radiol. 2021. PMID: 34114058. doi:10.1007/s00330-021-08097-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。